PUBLISHER: The Business Research Company | PRODUCT CODE: 1693262
PUBLISHER: The Business Research Company | PRODUCT CODE: 1693262
Medicated bath additives are products designed to be added to bathwater for therapeutic benefits or to address specific skin or health issues. They are used to treat skin conditions, promote relaxation, relieve muscle aches, and offer other therapeutic effects.
The main products of medicated bath additives include bath bombs, bath soaps, shower gels, shampoos, conditioners, and accessories. Bath bombs are compacted mixtures of dry ingredients that effervesce when submerged in water, releasing fragrances, oils, and additives. These products are available in various forms such as solids, gels, jellies, and liquids, suitable for both males and females. They are distributed through various channels including retail pharmacies, supermarkets or hypermarkets, online sales, general stores, and cosmetic stores.
The medicated bath additives market research report is one of a series of new reports from The Business Research Company that provides medicated bath additives market statistics, including medicated bath additives industry global market size, regional shares, competitors with medicated bath additives market share, detailed medicated bath additives market segments, market trends, and opportunities, and any further data you may need to thrive in the medicated bath additives industry. This medicated bath additives market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The medicated bath additive market size has grown strongly in recent years. It will grow from $31.45 billion in 2024 to $33.89 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to need for improving skin tone, increasing demand for affordable bathing additive products, consumption of premium bath bombs and bubbles, increasing demand for powder type bath additives, growing demand for adult type bath additives.
The medicated bath additive market size is expected to see strong growth in the next few years. It will grow to $45.46 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to rising preference for natural products, rise of biotechnology-inspired formulations, demand of aromatherapy, rise in maintaining personal health, growing awareness about hygiene issues. Major trends in the forecast period include growing trend of refillable packaging, changing consumer preferences, introduction of innovative product offerings, growing emphasis on health and wellness, introduction of wide range of product offerings.
The increasing prevalence of skin conditions is anticipated to drive the growth of the medicated bath additive market. Skin conditions encompass various abnormalities, disorders, or diseases affecting the skin, the body's largest organ. The rising occurrence of these conditions has led to a growing demand for medicated bath additives, which deliver active ingredients directly to the skin for targeted therapeutic effects, alleviating symptoms, and promoting skin health. For instance, in 2022, the International Eczema Council, a U.S.-based organization, reported that approximately 223 million people globally were affected by atopic dermatitis, with around 43 million aged between 1 and 4 years. As a result, the rising prevalence of skin conditions is fueling growth in the medicated bath additive market.
Major companies in the medicated bath additive market are innovating with products such as medicated body care items to meet the needs of people engaged in workouts and recovery. Medicated body care products are personal care items containing active ingredients intended to treat or prevent specific skin conditions. For example, in March 2022, Degree by Unilever Plc launched new deodorant and body care products, including Maximum Recovery skin cleansing products. The Degree Maximum Recovery Body Wash & Soaks, containing Epsom salts, electrolytes, and mood-boosting fragrance technology, are designed for use with hot water in showers for recovery. Massage bars relieve tension, cleanse and refresh skin, and can double as bubble baths.
In February 2022, Taro Pharmaceutical Industries Ltd., a US-based pharmaceutical company, acquired Alchemee for an undisclosed amount. The acquisition aims to enhance Taro Pharmaceutical Industries Ltd.'s position in the over-the-counter medicated bath additive and products market by adding Alchemee's assets and resources, including the Proactiv brand. Alchemee is a US-based health, wellness, and fitness company specializing in skin and bathing health, direct marketing, and acne products.
Major companies operating in the medicated bath additive market report are Johnson & Johnson, LVMH Moet Hennessy Louis Vuitton S.E., Unilever plc, L'Oreal S.A., Reckitt Benckiser Group plc, Estee Lauder Companies Inc., Galderma S.A., Revlon Inc., Croda International plc, Lupin Limited, L'Occitane International S.A., Piramal Pharma Limited, Kneipp GmbH, Shanghai Jahwa United Co. Ltd., Lush Cosmetics Ltd., Almirall S.A., Himalaya Wellness Company, Weleda AG, Fine Organic Industries Limited, Tom's of Maine Inc., Herbivore Botanicals LLC, Westlab ltd., Acure Organics, Borghese Inc., Nardo's Naturals, Soothing Touch, The Mother Soap Co., Buff City Soap, Bath & Body Works, The Body Shop
North America was the largest region in the medicated bath additive market in 2024. The regions covered in the medicated bath additive market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the medicated bath additive market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The medicated bath additive market consists of sale of cleansers, medications, herbs, essential oils, and other compounds. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Medicated Bath Additive Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on medicated bath additive market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for medicated bath additive ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The medicated bath additive market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.